NCT00114855View on ClinicalTrials.gov

The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

June 30, 2006

Conditions
HyperlipidemiaGlucose Metabolism Disorders
Interventions
DRUG

HYPOCOL®

Trial Locations (1)

0027

Lipidklinikken, Rikshospitalet, Oslo

Sponsors

Collaborators (1)

Pharmalogica
All Listed Sponsors
collaborator

Pharmalogica

INDUSTRY

collaborator

Wearnes Biotech @ Medicals

UNKNOWN

collaborator

Beijing Peking University WBL Biotech Co., Ltd.

INDUSTRY

lead

Oslo University Hospital

OTHER